BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND NDRG1, NDR1, 10397, ENSG00000104419, Q92597, RIT42, CMT4D, TARG1, HMSNL, GC4, RTP, TDD5, PROXY1, NMSL, CAP43
17 results:

  • 1. Disulfiram suppresses epithelial-mesenchymal transition (EMT), migration and invasion in cervical cancer through the HSP90A/ndrg1 pathway.
    Zheng P; Wu Y; Wang Y; Hu F
    Cell Signal; 2023 Sep; 109():110771. PubMed ID: 37329997
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Molecular classification of human papillomavirus-positive cervical cancers based on immune signature enrichment.
    Song G; Luo J; Zou S; Lou F; Zhang T; Zhu X; Yang J; Wang X
    Front Public Health; 2022; 10():979933. PubMed ID: 36203656
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Deferasirox shows inhibition activity against cervical cancer in vitro and in vivo.
    Zhou N; Cui Y; Zhu R; Kuang Y; Ma W; Hou J; Zhu Y; Chen S; Xu X; Tan K; Cao P; Duan X; Fan Y
    Gynecol Oncol; 2022 Jul; 166(1):126-137. PubMed ID: 35688655
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Differential transcriptome analysis in HPV-positive and HPV-negative cervical cancer cells through CRISPR knockout of miR-214.
    Sen P; Ganguly P; Kulkarni KK; Budhwar R; Ganguly N
    J Biosci; 2020; 45():. PubMed ID: 32975231
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A combined ANXA2-ndrg1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer.
    Buttarelli M; Babini G; Raspaglio G; Filippetti F; Battaglia A; Ciucci A; Ferrandina G; Petrillo M; Marino C; Mancuso M; Saran A; Villani ME; Desiderio A; D'Ambrosio C; Scaloni A; Scambia G; Gallo D
    J Exp Clin Cancer Res; 2019 Jun; 38(1):279. PubMed ID: 31242951
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Suppressive effect of microRNA-449a on the ndrg1/PTEN/AKT axis regulates endometrial cancer growth and metastasis.
    Wu AY; Hu Y; Cang W; Li D; Wang WJ; Tian Q; Gu LY; Zhang N; Ji F; Qiu LH
    Exp Cell Res; 2019 Sep; 382(2):111468. PubMed ID: 31201812
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. FOXD3 is a novel tumor suppressor that affects growth, invasion, metastasis and angiogenesis of neuroblastoma.
    Li D; Mei H; Qi M; Yang D; Zhao X; Xiang X; Pu J; Huang K; Zheng L; Tong Q
    Oncotarget; 2013 Nov; 4(11):2021-44. PubMed ID: 24269992
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. N-myc downstream-regulated gene 1/cap43 may function as tumor suppressor in endometrial cancer.
    Lv XH; Chen JW; Zhao G; Feng ZZ; Yang DH; Sun WW; Fan JS; Zhu GH
    J Cancer Res Clin Oncol; 2012 Oct; 138(10):1703-15. PubMed ID: 22678098
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identification of ndrg1-regulated genes associated with invasive potential in cervical and ovarian cancer cells.
    Zhao G; Chen J; Deng Y; Gao F; Zhu J; Feng Z; Lv X; Zhao Z
    Biochem Biophys Res Commun; 2011 Apr; 408(1):154-9. PubMed ID: 21463610
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Expression and biological function of N-myc down-regulated gene 1 in human cervical cancer.
    Wang J; Cai J; Li Z; Hu S; Yu L; Xiao L; Wang Z
    J Huazhong Univ Sci Technolog Med Sci; 2010 Dec; 30(6):771-6. PubMed ID: 21181370
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Identifying pH independent hypoxia induced genes in human squamous cell carcinomas in vitro.
    Sørensen BS; Toustrup K; Horsman MR; Overgaard J; Alsner J
    Acta Oncol; 2010 Oct; 49(7):895-905. PubMed ID: 20429727
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. N-myc downstream-regulated gene 1 as a downregulated target gene of PTEN in the controlling of tumourigenesis in endometrioid carcinoma.
    Li S; Chen J; Yang Z; Lu G; Tang H; Hu H
    Indian J Med Res; 2008 May; 127(5):453-9. PubMed ID: 18653908
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Correlation between ndrg1 and PTEN expression in endometrial carcinoma.
    Chen J; Li S; Yang Z; Lu G; Hu H
    Cancer Sci; 2008 Apr; 99(4):706-10. PubMed ID: 18377423
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. cap43/ndrg1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma.
    Nishio S; Ushijima K; Tsuda N; Takemoto S; Kawano K; Yamaguchi T; Nishida N; Kakuma T; Tsuda H; Kasamatsu T; Sasajima Y; Kage M; Kuwano M; Kamura T
    Cancer Lett; 2008 Jun; 264(1):36-43. PubMed ID: 18281151
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Microarray analysis of normal cervix, carcinoma in situ, and invasive cervical cancer: identification of candidate genes in pathogenesis of invasion in cervical cancer.
    Song JY; Lee JK; Lee NW; Jung HH; Kim SH; Lee KW
    Int J Gynecol Cancer; 2008; 18(5):1051-9. PubMed ID: 18217980
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Large scale validation of human N-myc downstream-regulated gene (NDRG)-1 expression in endometrium during the menstrual cycle.
    Malette B; Cherry E; Lagacé M; Bernard M; Gosselin D; Hugo P; Shazand K
    Mol Hum Reprod; 2003 Nov; 9(11):671-9. PubMed ID: 14561810
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Cf-252 neutron therapy of cervical carcinoma: topometrical radiotherapy planning using an afterloading technic and computerized tomography].
    Merkle K; Spasokukotskaya ON
    Arch Geschwulstforsch; 1986; 56(3):203-10. PubMed ID: 3729681
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.